Plasma gelsolin modulates cellular response to sphingosine 1-phosphate.
Hypogelsolinemia is observed in patients with different states of acute or chronic inflammation such as sepsis, rheumatoid arthritis, and multiple sclerosis. In animal models of sepsis, repletion of plasma gelsolin reduces septic mortality. However, the functions of extracellular gelsolin and the mechanisms leading to its protective nature are poorly understood. Potential mechanisms involve gelsolin's extracellular actin scavenging function or its ability to bind bioactive lipids or proinflammatory mediators, which would limit inflammatory responses and prevent tissue damage. Here we report that human plasma gelsolin binds to sphingosine 1-phosphate (S1P), a pleiotropic cellular agonist involved in various immune responses, and to its synthetic structural analog FTY720P (Gilenya). The fluorescence intensity of a rhodamine B-labeled phosphatidylinositol 4,5-bisphosphate binding peptide derived from gelsolin and the optical density of recombinant human plasma gelsolin (rhpGSN) were found to decrease after the addition of S1P or FTY720P. Gelsolin's ability to depolymerize F-actin also decreased progressively with increasing addition of S1P. Transient increases in phosphorylation of extracellular signal-regulated kinase in bovine aortic endothelial cells (BAECs) after S1P treatment were inhibited by rhpGSN. The ability of S1P to increase F-actin content and the elastic modulus of primary astrocytes and BAECs was also prevented by rhpGSN. Evaluation of S1P and gelsolin levels in cerebrospinal fluid reveals a low concentration of gelsolin and a high concentration of S1P in samples obtained from patients suffering from lymphatic meningitis. These findings suggest that gelsolin-mediated regulation of S1P bioactivity may be important to maintain immunomodulatory balance at inflammatory sites.
Bucki
Robert
R
Univ. of Pennsylvania, Inst. for Medicine and Engineering, 1010 Vagelos Research Laboratories, 3340 Smith Walk, Philadelphia, PA 19104, USA. buckirob@mail.med.upenn.edu
Kulakowska
Alina
A
Byfield
Fitzroy J
FJ
Zendzian-Piotrowska
Malgorzata
M
Baranowski
Marcin
M
Marzec
Michal
M
Winer
Jessamine P
JP
Ciccarelli
Nicholas J
NJ
Górski
Jan
J
Drozdowski
Wieslaw
W
Bittman
Robert
R
Janmey
Paul A
PA
D000199:Actins / Q000378:metabolism; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D002417:Cattle; D002460:Cell Line; D048049:Extracellular Signal-Regulated MAP Kinases / Q000032:analysis / Q000378:metabolism; D018260:Gelsolin / Q000097:blood* / Q000134:cerebrospinal fluid / Q000378:metabolism; D006801:Humans; D008206:Lymphatic Diseases / Q000378:metabolism; D008246:Lysophospholipids / Q000134:cerebrospinal fluid / Q000378:metabolism*; D008581:Meningitis / Q000378:metabolism; D010755:Organophosphates / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000134:cerebrospinal fluid / Q000378:metabolism
D000199:Actins; C525008:FTY 720P; D018260:Gelsolin; D008246:Lysophospholipids; D010755:Organophosphates; C060506:sphingosine 1-phosphate; D048049:Extracellular Signal-Regulated MAP Kinases; D013110:Sphingosine
J Biol Chem. 1971 Aug 10;246(15):4866-71
4254541
J Cell Sci. 2005 Oct 15;118(Pt 20):4605-12
16219683
J Biol Chem. 2001 Nov 16;276(46):43390-9
11533030
Arthritis Res Ther. 2008;10(5):R117
18822171
PLoS One. 2008;3(11):e3712
19002257
Cell. 1997 Aug 22;90(4):661-70
9288746
J Immunol. 2008 Oct 1;181(7):4936-44
18802097
Anal Biochem. 2002 Apr 15;303(2):167-75
11950216
Eur J Neurosci. 2006 Mar;23(6):1453-64
16553609
EMBO J. 1998 Oct 15;17(20):5923-32
9774337
Stem Cells. 2007 Jan;25(1):115-24
16990586
J Lipid Res. 2009 Nov;50(11):2245-57
19509417
Biochim Biophys Acta. 2006 Jan;1758(1):85-9
16460666
Eur J Neurol. 2008 Jun;15(6):584-8
18474076
Trends Mol Med. 2006 Feb;12(2):65-75
16406843
Ann Surg. 2006 Mar;243(3):399-403
16495706
Nature. 1979 Oct 18;281(5732):583-6
492320
Am J Physiol Cell Physiol. 2007 Apr;292(4):C1323-30
17135294
J Biol Chem. 2005 Apr 29;280(17):17320-8
15728185
J Biol Chem. 1992 Jun 15;267(17):11818-23
1318302
Biochemistry. 2005 Jul 19;44(28):9590-7
16008344
Biochem Biophys Res Commun. 2007 Aug 3;359(3):649-54
17544365
Blood. 1987 Aug;70(2):524-30
3038216
Blood. 2002 Dec 15;100(13):4367-71
12393536
J Biol Chem. 2002 Jul 19;277(29):25851-4
12011102
Prostaglandins Other Lipid Mediat. 2001 Apr;64(1-4):11-20
11324701
Int Immunol. 2008 Jul;20(7):911-23
18495625
Curr Protein Pept Sci. 2008 Dec;9(6):541-51
19075745
J Clin Invest. 1986 Sep;78(3):736-42
3018044
Pharmacol Ther. 2007 Jul;115(1):84-105
17561264
Eur J Biochem. 1981;114(1):33-8
7011802
N Engl J Med. 1992 May 14;326(20):1335-41
1314333
Am J Obstet Gynecol. 2009 Feb;200(2):191.e1-4
19110227
Am J Physiol Cell Physiol. 2007 Apr;292(4):C1240-2
17428843
Antimicrob Agents Chemother. 2006 Sep;50(9):2932-40
16940084
Trends Immunol. 2007 Mar;28(3):102-7
17276731
Clin Chem. 2009 Jun;55(6):1218-22
19325012
Biochem J. 2000 Dec 15;352 Pt 3:809-15
11104690
J Biol Chem. 2000 May 12;275(19):14573-8
10799543
Mol Pharmacol. 2003 Nov;64(5):1199-209
14573770
Am J Transplant. 2006 Jul;6(7):1560-71
16827856
FASEB J. 2003 Aug;17(11):1411-21
12890694
Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1673-81
10556139
J Biol Chem. 2004 Apr 2;279(14):13839-48
14732717
Neurosci Lett. 2010 Jun 25;477(3):149-52
20434523
Immunol Rev. 2003 Oct;195:160-77
12969317
Methods Mol Biol. 2008;491:103-11
18998087
Biophys J. 2009 Apr 8;96(7):2727-33
19348755
Atherosclerosis. 2007 Sep;194(1):159-68
17118370
Tissue Eng Part A. 2009 Jan;15(1):147-54
18673086